Reimbursement Acceleration Opportunity to engage with CMS and payer ecosystems to expedite coverage for XTRAC excimer laser treatments, leveraging STRATA’s recent CMS code facilitation to drive faster adoption and patient access.

Strategic Partnerships Target expansion via collaboration with medical payers, clinics, and dermatology networks, highlighting STRATA’s in-office dermatologic solutions and the potential to bundle devices with service models to increase market penetration.

Clinical Adoption Momentum Capitalize on ongoing investor and industry conference appearances to cultivate partnerships with dermatology practices and hospital systems, using executive leadership visibility to generate speculative interest in large deployments.

Financing & Capital Leverage recent financing activity and continued access to capital to propose financing-friendly procurement options for clinics, enabling higher device adoption and expedited ROIs for new customers.

Competitive Positioning Differentiate STRATA’s XTRAC and skin-treatment portfolio against peers by emphasizing in-office treatment efficiency, expanded reimbursement pathways, and a history of comeback placements to reassure clinics of dependable performance and service support.